Xsensio SA

About Xsensio SA

Xsensio is pioneering a new era of patient monitoring with its Lab-on-Skin™ sensing platform, designed for real-time, continuous tracking of inflammation and critical biomarkers. The technology enables early detection of clinical deterioration across various settings, from ICU to outpatient care and home, empowering healthcare providers with actionable data for timely care decisions.

Products & Services

Lab-on-Skin™ Sensing Platform:A highly-miniaturized sensing chip for continuous health monitoring, focusing on real-time tracking of inflammation and biomarkers, with applications in early detection of organ dysfunction in critical care, oncology, and post-surgical recovery.

Specialties

Real-time biochemical sensing Patient monitoring Continuous health tracking Early detection of clinical deterioration

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 7000000 MR: - FA: $7M FAN: 7000000	D: 2026-03-02 FD: 2026-03-02	4 investors

Series A Latest

2026-03-02

$7.0M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

E

Esmeralda Megally

CEO & Co-Founder

A

Adrian Ionescu

CTO & Co-Founder

A

Ali Saeidi

Director of Product Development

J

Johan Longo

Head of Chemistry

K

Karin Jaymes

Co-Founder and Manager

Y

Yann Sprunger

Senior Clinical Scientist

View 17 more team members with Pro

Unlock Full Team Directory

Recent News

Xsensio SA Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised